Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Thematic (Sector/Industry)

United states Health care / Thematic (Sector/Industry)

<ul><li class="p1">Over the next decade, we expect orthopedic innovation in extremities, robotics, and 3-D printing to be key drivers of growth as fee-for-value reimbursement and slowing advancements weigh on the traditional large joint replacement market.</li><li class="p1">In particular, we think the extremities market— representing 50% of projected incremental orthopedic sales from 2015–2020—is an important growth avenue that has not been carefully examined by the investment community.</li></ul><p><em>Analyst: Debbie Wang</em></p>

Over the next decade, we expect orthopedic innovation in extremities, robotics, and 3-D printing to be key drivers of growth as fee-for-value reimbursement and slowing advancements weigh on the traditional large joint replacement market.In particular, we think the extremities market— representing 50% of projected incremental orthopedic sales from 2015–2020—is an important growth avenue that has not been carefully examined by the investment community.Analyst: Debbie Wang

West Pharmaceutical Services Inc (WST US)

Mettler Toledo International Inc (MTD US)

Laboratory Corporation of America Holdings (LH US)

Laboratory Corporation of America Holdings

Healthcare Observer: Orthopedic Innovation Beyond Large Joint Market Fuels Long-Term Growth